CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) is pleased to announce the recent publication of the 16 th Annual Hemovigilance report by the French National Agency for Medicines and ...
Well-established hemovigilance programs have been in place for a number of years in some developed countries. [7] The Serious Hazard of Transfusion program of the United Kingdom, for instance, ...
Guidelines, audits and hemovigilance have become an integral part to ensure the safety of the blood components that are used in the treatment of patients. These systems tend to be very sophisticated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results